Turn Therapeutics Inc.
TTRXTurn Therapeutics reported deepened GAAP operating losses of -$5.9M amid clinical development investments, partially offset by non-cash gains resulting in net loss of -$3.2M and diluted EPS of -$0.12, with cash burn reflecting ongoing R&D ramp-up.
NASDAQ
Healthcare
Biotechnology
$3.32
+0.20(6.43%)
52W $2.71 – $9.20
AI-generated
Turn Therapeutics reported deepened GAAP operating losses of -$5.9M amid clinical development investments, partially offset by non-cash gains resulting in net loss of -$3.2M and diluted EPS of -$0.12, with cash burn reflecting ongoing R&D ramp-up.
$98MMkt Cap
—Rev TTM
—NI TTM
Latest Earnings
10-K
FY FY2025Mar 30, 2026Turn Therapeutics reported deepened GAAP operating losses of -$5.9M amid clinical development investments, partially offset by non-cash gains resulting in net loss of -$3.2M and diluted EPS of -$0.12, with cash burn reflecting ongoing R&D ramp-up.
What Changed Recently
Fundamentals
How The Business Makes Money
Global Health Solutions, Inc., doing business as Turn Therapeutics, operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. Global Health Solutions, Inc. was incorporated in 2015 and is based in Westlake Village, California.
Industry Biotechnology
Analyst View
Company Profile
CIK0002023016
ISINUS90021W1053
CUSIP90021W105
Phone818 546 4011
Address250 N Westlake Blvd, Westlake Village, CA, 91362, US
SEC EDGAR